Zomig (zolmitriptan) is a prescription drug that’s used to treat migraine headaches. The drug comes in different forms, including a nasal spray. It’s usually used at the onset of a migraine episode.

The sole question on appeal was whether it would have been obvious to make zolmitriptan into a nasal spray. The Federal Circuit agreed with the district court that the prior art taught away from ...

BRIDGEWATER, N.J., June 29, 2018 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that a panel of three Circuit Judges of the U.S. Court of Appeals for the Federal Circuit has ...

The US Food and Drug Administration (FDA) has approved zolmitriptan nasal spray (Zomig, Impax Specialty Pharma) for the acute treatment of migraine with or without aura in children 12 years of age and ...

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Pharmaceuticals, the branded products business unit of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today that it has licensed from AstraZeneca the ...

A 41-year-old man uses zolmitriptan (Zomig Nasal Spray) every other day, sometimes daily, for severe migraine headache. He has hyperlipidemia and metabolic syndrome, and he is under stress. Is there ...

NEW YORK (Reuters Health) - A nasal spray containing the drug zolmitriptan, which is known by the brand name Zomig, effectively relieves migraine headache in adolescents and is well tolerated, ...

WASHINGTON, Aug 27 (Reuters) - A nose spray made using AstraZeneca Plc's migraine drug Zomig can help patients with painful cluster headaches, U.S. researchers said on Monday. A study of 52 people ...

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that its generics division, Global Pharmaceuticals, commenced shipment of authorized generic Zomig® ...